The first gynecological visit includes a detailed medical interview, discussion of the menstrual cycle and symptoms, as well as a gynecological examination and pelvic ultrasound. It is an important step in intimate health prevention – allowing early detection of potential abnormalities and planning further care. The visit is conducted in a comfortable and discreet atmosphere, respecting the patient's privacy.

The follow-up gynecological visit is an opportunity to monitor intimate health, review previous test results, and adjust treatment if necessary. The visit includes a gynecological examination and pelvic ultrasound. Regular check-ups allow early detection of changes and help maintain good health. The consultation is conducted in a friendly and professional atmosphere.

The visit includes discussion of previously performed test results (e.g., cytology, ultrasound, hormones, swabs) and their interpretation by a gynecologist. During the consultation, further diagnostics or treatment can be planned depending on the results. The meeting aims to provide the patient with full understanding of her health status and support for further management.

A remote consultation with a gynecologist or obstetrician is a convenient form of contact, allowing discussion of symptoms, test results, pregnancy-related complaints, or questions regarding contraception, menstrual cycle, or pregnancy planning. The doctor provides professional recommendations and can issue an e-prescription or referral for tests. The tele-consultation takes place from home, ensuring confidentiality and full professionalism.

The visit combines assessment of gynecological health with hormonal disorder diagnostics. The consultation includes a detailed medical interview, analysis of the menstrual cycle, symptoms such as acne, excessive hair growth, weight or fertility issues, and evaluation of hormonal test results. The doctor tailors an individual diagnostic and therapeutic plan, considering the influence of hormonal balance on reproductive system function.

A specialized consultation aimed at couples or women who have been trying to conceive without success for at least 12 months (or 6 months for women over 35). The visit includes a detailed medical history, analysis of previous test results, menstrual cycle, lifestyle, and any existing health conditions. The doctor proposes further diagnostics and an individually tailored plan of action to identify the causes of conception difficulties and increase the chances of pregnancy.

Sono-HSG, or ultrasound hysterosalpingography, is a non-invasive method that allows assessment of the fallopian tubes and uterine cavity. The examination is a key element in infertility diagnostics, enabling the detection of potential tubal blockages and uterine anatomical abnormalities that may hinder conception or pregnancy maintenance. Sono-HSG is a safe, quick, and effective procedure to identify causes of fertility issues in many patients.

The examination is recommended for women who have difficulty conceiving, especially if tubal obstruction or uterine abnormalities are suspected. Blocked fallopian tubes can prevent fertilization, and an abnormal uterine shape may increase the risk of miscarriage. Sono-HSG is an important step in infertility diagnostics and can help determine further procedures, including indications for in vitro fertilization.

Prior to Sono-HSG, diagnostic tests such as cytology, cervical canal cultures, and virological tests (HIV 1,2 antibodies, HBS antigen, VDRL, Anti-HBc, Anti-HCV) must be performed. If the procedure is done under general anesthesia, the patient should be fasting. For procedures without anesthesia, a light breakfast is recommended. On the day of the examination, the bladder should be filled.

The examination is performed in a gynecological office. The doctor inserts a speculum into the vagina, followed by a thin catheter with a small balloon, which is placed in the cervix. After inflation, a special contrast is administered into the uterine cavity and fallopian tubes, allowing real-time assessment of tubal patency using ultrasound. On the ultrasound screen, the doctor observes the flow, analyzing the shape, size, and any obstructions in the reproductive tract.

The entire procedure lasts approximately 15–20 minutes, and the results are available immediately after the examination. In some cases, the contrast can help open slightly adhered fallopian tubes, increasing the chances of natural conception.

At Pozmedica Clinic, we prioritize patient comfort and professional care at every stage of diagnostics and treatment. We invite you to contact us and schedule a Sono-HSG examination.

Conventional (glass-slide) Pap smear is a basic preventive test for cervical cancer. It involves collecting a sample from the cervix and placing it on a microscope slide to evaluate epithelial cells. The test allows detection of precancerous conditions, infections (including HPV), and other abnormalities. It is quick, painless, and recommended regularly – ideally once a year – as part of intimate health prevention.

Liquid-based cytology is a modern and more precise form of cytological examination. It involves collecting cells from the cervix and placing them in a special liquid, which allows better preservation and more accurate microscopic evaluation. This method increases the detection of precancerous changes and infections, including HPV. Liquid-based cytology is recommended as a more effective alternative to conventional Pap smear for cervical cancer prevention.

The combination of liquid-based cytology (LBC) with DNA HPV testing is a modern and highly effective method for early detection of precancerous cervical changes. The examination assesses epithelial cells while simultaneously detecting 14 high-risk HPV types responsible for cervical cancer development. This combination allows for more precise diagnostics and individualized risk assessment. Particularly recommended for women over 30 years old or with abnormal cytology results.

This advanced test combines liquid-based cytology with the CinTec immunocytochemical test, which detects the presence of p16 and Ki-67 proteins – markers indicating precancerous changes in the cervix. This allows for more precise differentiation between benign changes and those requiring further diagnostics and treatment. The test increases the detection of high-risk conditions and helps in precise gynecological care planning. Particularly recommended for ambiguous or suspicious cytology results.

The test detects the DNA of 14 high-risk human papillomavirus (HPV) types, which are the main cause of cervical cancer. It determines whether the patient carries any of these virus types, even if no symptoms or cytological changes are present yet. This is a valuable tool for prevention and early detection of cancer risk. Particularly recommended for women over 30 and as a supplement to diagnostics when cytology results are abnormal.

The advanced HPV DNA test allows detection of up to 32 human papillomavirus types, including high-risk types (associated with cervical cancer risk) and low-risk types (responsible, among others, for genital warts). The test precisely identifies the presence and type of HPV virus, aiding in health risk assessment and planning further diagnostics or treatment. Recommended for women as part of extended preventive care and for individuals with recurring viral changes.

The CinTec Test is a modern immunocytochemical examination performed on material collected from the cervix, detecting the presence of p16 and Ki-67 proteins – markers indicating abnormal cellular activity caused by high-risk HPV infection. The simultaneous presence of both markers indicates a higher risk of precancerous changes. The test is especially useful for evaluating ambiguous cytology results and confirmed HPV infection, helping to determine the need for further diagnostics or treatment.

Vaginal culture is a microbiological test aimed at identifying aerobic and anaerobic bacteria as well as fungi (e.g., Candida) that can cause inflammatory conditions of the reproductive tract. It allows precise determination of the type of pathogen and its sensitivity to antibiotics or antifungal medications, enabling effective and targeted treatment. The test is recommended for symptoms such as discharge, burning, itching, unpleasant odor, or recurrent intimate infections.

The test involves taking a swab from the vagina and/or rectum to detect the presence of Group B Streptococcus (Streptococcus agalactiae). This bacterium can reside in the female reproductive tract asymptomatically, but during delivery it poses a risk of infecting the newborn. GBS screening is routinely performed in pregnant women between the 35th and 37th week of gestation. A positive result allows for appropriate antibiotic prophylaxis during labor to protect the baby from complications.

Microbiological test aimed at detecting sexually transmitted bacteria: Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum/parvum. The swab allows identification of the pathogen and assessment of its antibiotic sensitivity, enabling effective treatment. Recommended in cases of symptoms such as discharge, burning, pain during urination, difficulties conceiving, or as part of the diagnostic workup for genitourinary infections. The test can be performed on samples from the cervical canal, urethra, or urine.

Vaginal biocenosis is a microscopic examination of a vaginal swab that assesses the composition and balance of the natural bacterial flora of the reproductive tract. It determines the presence of Lactobacillus, pathogenic bacteria, fungi, and inflammatory cells. The result is classified according to vaginal cleanliness grades (I–IV), which helps diagnose inflammatory conditions, microbiological imbalance, and select appropriate treatment. The test is quick, painless, and recommended for recurrent intimate infections or prior to gynecological procedures.

Gardasil 9 is a modern vaccine protecting against 9 types of human papillomavirus (HPV), including the most oncogenic types (e.g., 16 and 18) and those responsible for genital warts. The vaccination effectively prevents the development of cervical, vulvar, vaginal, and anal cancers, as well as HPV-related skin lesions. It is recommended for both girls and boys from 9 years old, as well as adults – especially before the onset of sexual activity, but also later in life. Administered in a series of 2 or 3 doses depending on the patient’s age.

A short consultation aimed at issuing a prescription to continue previously recommended treatment – including hormonal contraception, gynecological medications, supplements, or hormonal preparations. The visit does not include a physical examination but may include a brief assessment of the patient’s health status and current needs. This service is intended for individuals under regular medical care with a documented treatment history.

An intrauterine device (IUD) with gold or silver ions is a modern, non-hormonal form of long-term contraception. The noble metal ions have anti-inflammatory and antibacterial effects, reducing the risk of infection and improving IUD tolerance. The procedure involves the insertion of the intrauterine system by a gynecologist in an outpatient setting, usually during or immediately after menstruation. This method provides effective protection against pregnancy for 5 to 10 years without affecting the body's hormonal balance.

The procedure involves the professional insertion of an intrauterine device (IUD) provided by the patient. The IUD can be hormonal or non-hormonal, and its placement in the uterus is performed in an outpatient setting by a gynecologist. The procedure is quick and usually carried out during or immediately after menstruation. After insertion, the doctor provides guidance on further care, monitoring for potential symptoms, and follow-up appointments. This service ensures effective, long-term contraception according to the patient’s choice.

Kyleena is a hormonal intrauterine device containing a low dose of levonorgestrel, an effective method of long-term contraception (up to 5 years). The procedure involves insertion of the device by a gynecologist in an outpatient setting, usually during or just after menstruation. Kyleena acts locally to reduce the risk of pregnancy and often alleviates menstrual pain and heavy bleeding. After insertion, the doctor provides instructions regarding monitoring and follow-up appointments.

A procedure involving the safe and quick removal of an intrauterine device (hormonal or non-hormonal) by a gynecologist in an outpatient setting. The procedure is short and usually does not require anesthesia. Device removal is recommended after the suggested usage period, if the patient decides to change the contraceptive method, or if any discomfort occurs. After the procedure, the patient receives instructions regarding further care and planning of subsequent actions.

Laboratory microscopic examination of tissue collected during a surgical procedure or biopsy, aimed at assessing the morphology of cells and detecting possible pathological changes, including inflammatory conditions, precancerous lesions, and malignancies. This examination is essential for establishing a definitive diagnosis and selecting appropriate treatment. The histopathological analysis provides detailed information on the nature and extent of changes in the examined material.

Specialized cylindrical supporting tampon used in gynecology as post-surgical support or in the treatment of pelvic organ prolapse. The Contam tampon provides proper support and stabilization, facilitates tissue healing, and helps prevent infections. Easy to insert and comfortable to use.

The pessary should be used according to the doctor’s recommendations. It is usually applied for a specific period, after which it should be removed and, if necessary, replaced with a new one. Regular gynecological check-ups are recommended to monitor health status and treatment effectiveness.

The first gynecological-oncology visit is a specialized consultation intended for patients with suspected or diagnosed malignancies of the reproductive organs (cervix, uterus, ovaries, vulva). The visit includes a detailed medical interview, review of documentation and test results, as well as a gynecological examination and, if necessary, an ultrasound. The physician presents a preliminary diagnostic and therapeutic plan and, if indicated, recommendations for further treatment or monitoring. The consultation is conducted with empathy and full professionalism, focusing on comprehensive oncological care.

The follow-up gynecological-oncology visit is intended for patients undergoing oncological treatment or after its completion. It includes assessment of health status, review of follow-up test results, monitoring of therapy progress, and potential adjustment of further management. The physician may perform a gynecological examination and ultrasound to rule out disease recurrence or complications. The visit ensures continuity of care, support, and patient safety throughout the oncological treatment and observation process.

A specialized consultation aimed at assessing the patient’s health status prior to a planned surgical procedure. During the visit, the physician conducts a detailed medical history, reviews test results, evaluates indications and contraindications for surgery, and explains potential risks and the course of the procedure. The qualification also includes discussion of the type of anesthesia and preparation for hospitalization. This is a key step in planning safe and effective surgical treatment.

Endometriosis diagnosis includes a comprehensive assessment of clinical symptoms, medical history, gynecological examination, and advanced imaging techniques—most commonly transvaginal ultrasound, and in selected cases, magnetic resonance imaging (MRI). If necessary, the physician may recommend laparoscopic diagnosis, which allows definitive confirmation of the disease and simultaneous treatment of endometrial lesions. The visit aims to determine the cause of complaints such as painful menstruation, pain during intercourse, difficulties conceiving, or chronic pelvic pain. An individualized approach enables effective treatment and improves the patient’s quality of life.